Trials / Completed
CompletedNCT01951976
Yoga for Aromatase Inhibitor-associated Joint Pain
Evaluating Yoga for Aromatase Inhibitor-associated Joint Pain in Women With Breast Cancer: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether it might be practical and useful to investigate the effectiveness of yoga classes in relieving joint pain associated with the use of a class of medications known as aromatase inhibitors.
Detailed description
The study uses a single-arm design. All study participants will be assigned to an intervention condition in which they participate in group Iyengar yoga classes for 90 minutes twice per week for 12 weeks (total of 24 classes). Study outcomes are assessed: 1) following recruitment but prior to the first yoga class; and 2) within two weeks post-intervention (follow-up). Additionally, a brief assessment of pain will be conducted four weeks and eight weeks after the start of yoga classes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires | Participants will be asked to complete a set of questionnaires about their health and well-being on two occasions (baseline and follow-up). Each set of questionnaires will take about 45 minutes to complete. |
| OTHER | Yoga Classes | Iyengar yoga is a traditional form of Hatha yoga that has been used previously to address quality of life issues in women with breast cancer. Iyengar yoga classes for 90 minutes twice per week for 12 weeks (total of 24 classes). |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-03-01
- Completion
- 2016-06-01
- First posted
- 2013-09-27
- Last updated
- 2016-07-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01951976. Inclusion in this directory is not an endorsement.